In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart
IgE antibodies elicit powerful immune responses, recruiting effector cells to tumors more efficiently and with greater cytotoxicity than IgG antibodies. Consequently, IgE antibodies are a promising alternative to conventional IgG-based therapies in oncology (AllergoOncology). As the pharmacokinetics...
Збережено в:
| Автори: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2021-01-01
|
| Серія: | OncoImmunology |
| Предмети: | |
| Онлайн доступ: | http://dx.doi.org/10.1080/2162402X.2021.1966970 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
